Boston Scientific (BSX) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 27.0 | 3.05 | 2.50 | 36.1 | 29.7 | 16.1 | ||
| Changes by years, y/y, % | -31% | -89% | -18% | +1 345% | -18% | -5.2% | |||
Boston Scientific. EV/EBITDA
Boston Scientific. EV/EBITDA, changes, %
Boston Scientific (BSX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 38.5 | 36.1 | 30.9 | 28.8 | 18.1 | 16.1 | |
| Changes by years, y/y, % | +1 515% | +1 547% | -12% | -21% | -53% | |||
| Changes by quarters, q/q, % | +6% | -6% | -14% | -7% | -37% | |||